Showing results (81-90 of 288) with videos related to

Sort By:
Pageof 29
The Journal of Heart Valve Disease|March 15, 2017
Left Ventricular Outflow Tract Obstruction and Systolic Anterior Motion of the Mitral Valve in the Absence of Hypertrophic CardiomyopathyNatasha Aleksova, Alice Wang, Christopher A Glover, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 27, 2015
Cost-effectiveness of Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir+Ribavirin for US Post-Liver Transplant Recurrent Genotype 1 HCVSammy Saab, Yuri S Gonzalez, Caroline Huber, et al.
Photochemistry and Photobiology|April 22, 2008
Photoprotection by porcine eumelanin against singlet oxygen productionAlice Wang, Anthony R Marino, Zbigniew Gasyna, et al.
The Journal of Infectious Diseases|October 12, 2011
Filovirus outbreak detection and surveillance: lessons from BundibugyoAdam MacNeil, Eileen C Farnon, Oliver W Morgan, et al.
MMWR. Morbidity and Mortality Weekly Report|February 24, 2022
Antigen Test Positivity After COVID-19 Isolation - Yukon-Kuskokwim Delta Region, Alaska, January-February 2022Brian Lefferts, Ian Blake, Dana Bruden, et al.
MMWR. Morbidity and Mortality Weekly Report|January 8, 2021
Time from Start of Quarantine to SARS-CoV-2 Positive Test Among Quarantined College and University Athletes - 17 States, June-October 2020Christine Atherstone, Meaghan L Peterson, Mackenzie Malone, et al.
MMWR. Morbidity and Mortality Weekly Report|January 28, 2021
Implementation and Evolution of Mitigation Measures, Testing, and Contact Tracing in the National Football League, August 9-November 21, 2020Christina D Mack, Erin B Wasserman, Cria G Perrine, et al.
Emerging Infectious Diseases|June 18, 2004
SARS in healthcare facilities, Toronto and TaiwanL Clifford McDonald, Andrew E Simor, Ih-Jen Su, et al.
Emerging Infectious Diseases|July 31, 2012
Solid organ transplant-associated lymphocytic choriomeningitis, United States, 2011Adam Macneil, Ute Ströher, Eileen Farnon, et al.
Pharmacoeconomics|December 10, 2014
Cost effectiveness of dabrafenib as a first-line treatment in patients with BRAF V600 mutation-positive unresectable or metastatic melanoma in CanadaThomas E Delea, Jordan Amdahl, Alice Wang, et al.
Pageof 29